Real-world implementation of lecanemab in Alzheimer's disease: A Japanese cohort. (PubMed, Alzheimers Dement (Amst)) - Sep 27, 2026 - "Lecanemab was feasible and generally well tolerated under structured MRI monitoring in routine Japanese practice."
Journal • Real-world evidence • Alzheimer's Disease • CNS Disorders • Dementia • Hematological Disorders
|
|
Daisuke Ito; Hajime Tabuchi; Hiroi Tomioka; Hiroki Sasaguri; Jin Nakahara; Koji Sekiguchi; Masaru Mimura; Ryo Shikimoto; Sho Shimohama; Shogyoku Bun; Toshiki Takayama; Yoshinori Nishimoto; Yu Iwabuchi; Yu Mimura
|